Doctor's Profile

Dr. Shreshth Khanna

MD Pharmacology

Assistant professor, Department of Pharmacology

Reg. Number: DMC-73700

shreshthkhanna@gmail.com

About

About

Educational Qualifications

S.No. Degree Year of Completion Institute Name
1 MBBS 2015 SRHU
2 MD 2019 Swami Rama Himalayan
3 BCBR 2020 MAMC, NEW DELHI

Details of Teaching Experience

S.No. Designation Institution From To Duration
1 Assistant Professor HIMSR, NewDelhi 26-08-2022 Present
2 Senior Resident Maulana Azad Medical College 11-06-2019 18-07-2022 3 Years
3 Tutor Swami Rama, Himalayan University 15-04-2016 07-05-2019 3 Years

Publications (Last Three Years)

  1. Rana, Proteesh; Varughese, Bijo1; Roy, Vandana2; Khanna, Shreshth2; Kapoor, Seema1; Khanna, Ashwani3. Tuberculosis and comorbid depression: Association with serum indoleamine 2, 3-dioxygenase activity. Indian Journal of Pharmacology 57 (1): p 21-26, Jan–Feb 2025.
  2. Shreshth Khanna, Mayank Malik, & Razi Ahmad. (2025). Prescription audit and prescribing patterns of anti-diabetic drugs of the out-patient department of medicine in a tertiary care teaching hospital in south delhi, India. Journal of Population Therapeutics and Clinical Pharmacology, 32(3), 999-1008.
  3. Dr. Shreshth Khanna, Dr. Shikha Dwivedi, Dr. Annwesha Chaudhury, & Dr. Ayush Jain. (2025). optimizing medication use in the department of orthopedics: a prescription audit at a medical college teaching hospital in dehradun, Uttarakhand. Journal of Population Therapeutics and Clinical Pharmacology, 32(3), 535-543.
  4. Khanna, Shreshth. (2025).The impact of psychosis on mental health and quality of life of an individual. Intechopen.
  5. Khanna, Shreshth. (2025). Pharmacotherapy of Sleep Disorders.
  6. Khanna, Shreshth. (2024). Existing and Newer Therapies in the Management and Diagnosis of Schizophrenia.
  7. Bala, Suman & Sharma, Rohitash & Khanna, Shreshth & Singh, Yashpal & Yadav, Nikku & Dewan, Yashbir. (2023). A Study of Factors Associated with Adherence to Treatment in Patients with Epilepsy. Azerbaijan Pharmaceutical and Pharmacotherapy J. 22. 193-197.
  8. Rai, Niket & Chandel, Satish & Shetty, Manu & Rai, Geeta & Khanna, Shreshth & Jain, Kunal. (2023). Risk Stratification of COVID-19 Patients based on Proposed Simple Clinical Parameters Score: A Retrospective Observational Study. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. 17.
  9. Khanna, Shreshth & Pant, Suchita & Khanna, Harsh. (2023). Isoniazid-Induced Psychosis in a Patient with Pulmonary Tuberculosis: A Case Report. Case Reports in Neurology. 15. 76-80.
  10. Khanna S, Pant S, Khanna H (2021) Linezolid Induced Toxic Optic Neuropathy in Patient of Extensively Drug Resistant Pulmonary Tuberculosis. J Clin Exp Ophthalmol.12:900.
  11. Khanna S, Tayal V, Roy V. (2021) Amoxicillin /Clavulanic Acid Induced Mixed Hepatocellular-Cholestatic Hepatic Injury- A Rare Case Report J Pharamacovigil 9:334.
  12. Khanna S, Jain A, Kalra BS. Neuropsychiatric aspect of social isolation following a lockdown: A perspective. Indian J Community Fam Med 2021; 7:74-8.

Invited Talks and Lectures

  1. Poster Presentation: “Comparative evaluation of levetiracetam and valproic acid as monotherapy on cognitive impairment in patients of epilepsy AT 6 TH UAE EPILEPSY CONGRESS ORGANIZED BY ELAE , DUBAI, UAE 26 TH – 27 TH OCTOBER 2018.
  2. Poster Presentation: “Rationality of Vitamin Supplements in the Tertiary care Hospital.” AT 3 RD INTERNATIONAL CONFERENCE ON “NUTRACEUTICALS AND CHRONIC DISEASES” (INCD-2018) SWAMI RAMA HIMALAYAN UNIVERSITY DEHRADUN, UTTARAKHAND 14 TH – 16 TH SEPTEMBER 2018.
  3. Oral Presentation: “A STUDY TO EVALUATE THE ADHERENCE PATTERN AMONG PATIENTS OF EPILEPSY ON ANTI-EPILEPTIC DRUGS IN A TERTIARY CARE HOSPITAL”. IPSCON-2017 15 TH -17 TH FEBRUARY 2018.

Institutional Responsibilities

S.No. Name of the Committee Role
1 Patient Safety committee Medication safety officer
2 Prescription monitoring committee Member